Search results
Author(s):
Luca Paolucci
,
Asad Shabbir
,
Marco Lombardi
,
et al
Added:
5 months ago
Author(s):
Arditya Damarkusuma
,
Paula Mota
,
Billal Patel
,
et al
Added:
1 year ago
Author(s):
Arditya Damarkusuma
Added:
1 year ago
In this video, Dr Arditya Damarkusuma (Universitas Gadjah Mada, ID) presents his case report on aorto-ostial lesions, recently published in ICR Journal.This case covers the restenosis of a markedly protruding stent at the right coronary ostium in a 54-year old man, and is unusual in its 10-year longevity. Intravascular ultrasound-guided in-stent restenosis intervention using a wire bumper…
View more
Author(s):
Jacob Thomsen Lønborg
Added:
3 weeks ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent…
View more
Author(s):
Hyo-Soo Kim
Added:
2 months ago
ACC 25 - Findings from a stratified study investigating coronary stenting and bleeding risk suggest 3 months are the optimal duration of DAPT after PCI.Dr Hyo-Soo Kim (Seoul National University Hospital, KR) sits down to discuss the first randomized study stratifying patients receiving percutaneous coronary intervention with drug eluting stents according to bleeding risk based on the ARC HBR…
View more
Author(s):
Viktor Sasi
,
Gyula Szántó
,
Alexandru Achim
,
et al
Added:
1 year ago
Author(s):
Marianne Brodmann
Added:
4 months ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable…
View more
Author(s):
Roxana Mehran
Added:
1 year ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024.The ABILITY study (NCT04236609) aimed to evaluate the efficacy and safety of the Abluminus DES+ Sirolimus Eluting Stent System (SES) as compared to the XIENCE Everolimus Eluting Coronary Stent System in diabetic patients eligible for percutaneous coronary…
View more
TCT 23: AGENT IDE
Author(s):
Robert Yeh
Added:
1 year ago
Video
AF, Stent and Anticoagulant
Author(s):
Balen Abdulrahman
,
Richard J Jabbour
,
Nick Curzen
Added:
2 years ago
Article